Open access · CC-BY
via OpenAlex
Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
Stefania Gorini, Seung Kyum Kim, Marco Infante, Caterina Mammi, Sandro La Vignera, Andrea Fabbri, Iris Zamir Jaffe, Massimiliano Caprio
Frontiers in Endocrinology · 2019 · ▲ 89 citations
Abstract
The mineralocorticoid receptor (MR) was originally identified as a regulator of blood pressure, able to modulate renal sodium handling in response to its principal ligand aldosterone. MR is expressed in several extra-renal tissues, including the heart, vasculature, and adipose tissue. More recent studies have shown that extra-renal MR plays a relevant role in the control of cardiovascular and metabolic functions and has recently been implicated in the pathophysiology of aging. MR activation promotes vasoconstriction and acts as a potent pro-fibrotic agent in cardiovascular remodeling. Aging is associated with increased arterial stiffness and vascular tone, and modifications of arterial structure and function are responsible for these alterations. MR activation contributes to increase blood pressure with aging by regulating myogenic tone, vasoconstriction, and vascular oxidative stress. Importantly, aging represents an important contributor to the increased prevalence of cardiometabolic syndrome. In the elderly, dysregulation of MR signaling is associated with hypertension, obesity, and diabetes, representing an important cause of increased cardiovascular risk. Clinical use of MR antagonists is limited by the adverse effects induced by MR blockade in the kidney, raising the risk of hyperkalaemia in older patients with reduced renal function. Therefore, there is an unmet need for the enhanced understanding of the role of MR in aging and for development of novel specific MR antagonists in the context of cardiovascular rehabilitation in the elderly, in order to reduce relevant side effects.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fendo.2019.00584
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Gorini, S., Kim, S.K., Infante, M., Mammi, C., Vignera, S.L., Fabbri, A., Jaffe, I.Z., & Caprio, M. (2019). Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging. <em>Frontiers in Endocrinology</em>. https://doi.org/10.3389/fendo.2019.00584
Vancouver
Gorini S, Kim SK, Infante M, Mammi C, Vignera SL, Fabbri A, et al. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging. Frontiers in Endocrinology. 2019. doi:10.3389/fendo.2019.00584.
BibTeX
@article{stefania2019Roleof,
title = {Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging},
author = {Stefania Gorini and Seung Kyum Kim and Marco Infante and Caterina Mammi and Sandro La Vignera and Andrea Fabbri and Iris Zamir Jaffe and Massimiliano Caprio},
journal = {Frontiers in Endocrinology},
year = {2019},
doi = {10.3389/fendo.2019.00584},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Figshare 2022
Preprint · CC-BY
Vascular Aging and Arterial Stiffness
Advances in experimental medicine and biology 2018
Citation only
Aging of the Bone
The Journal of Steroid Biochemistry and Molecular Biology 2019
Citation only
Anabolic effects of vitamin D and magnesium in aging bone
Frontiers in Cardiovascular Medicine 2018
Open access · CC-BY
Arterial Stiffness: A Prognostic Marker in Coronary Heart Disease. Available Methods and Clinical Application
International Journal of Cardiology 2004
Preprint · OA
Arterial stiffness is increased in subjects with hypothyroidism
University of Missouri-Columbia 2026
Open access · US-GOV